最大呼气中期流量可检测α1-抗胰蛋白酶缺乏症的早期肺疾病
该研究在196例α1-抗胰蛋白酶缺乏症(AATD)患者中评估最大呼气中期流量(MMEF)与肺功能、健康状态及FEV1后续下降的关系。结果显示MMEF占预计值%与FEV1/FVC、FEV1占预计值%及CT肺密度呈曲线相关,FEV1/FVC正常但MMEF降低的患者健康状态更差且FEV1下降更快,提示MMEF降低是AATD早期肺疾病特征。
要点
- MMEF占预计值%与FEV1/FVC、FEV1占预计值%及CT肺密度呈曲线相关。
- FEV1/FVC正常但MMEF降低的AATD患者健康状态更差。
- FEV1/FVC正常但MMEF降低的AATD患者后续FEV1下降更快。
核心结论
- MMEF降低是AATD肺疾病的早期特征,与健康状态受损和FEV1更快下降相关。
研究设计与样本
- 在196例AATD患者中评估MMEF、FEV1、FEV1/FVC、健康状态、CT肺密度及FEV1后续下降。
主要发现
- MMEF占预计值%与FEV1/FVC(r2=0.778,p<0.0001)、FEV1占预计值%(r2=0.787,p<0.0001)及CT肺密度(r2=0.594,p<0.0001)呈曲线相关。
- FEV1/FVC正常且MMEF降低组(组2)的SGRQ总分中位数为23.15(IQR 7.09-39.63),高于FEV1/FVC正常且MMEF正常组(组1)的9.67(IQR 1.83-22.35),p=0.006。
- 组2的FEV1年下降中位数为-1.09%预计值/年(IQR -1.91-0.04),组1为-0.04%预计值/年(IQR -0.67-0.03),p=0.007。
临床怎么用
- 在AATD患者中,即使FEV1/FVC正常,也应关注MMEF占预计值%是否降低以识别早期肺疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pathological studies suggest that loss of small airways precedes airflow obstruction and emphysema in chronic obstructive pulmonary disease (COPD). Not all α1-antitrypsin deficiency (AATD) patients develop COPD, and measures of small airways function might be able to detect those at risk.Maximal mid-expiratory flow (MMEF), forced expiratory volume in 1 s (FEV1), ratio of FEV1/forced vital capacity (FVC), health status, presence of emphysema (computed tomography (CT) densitometry) and subsequent decline in FEV1 were assessed in 196 AATD patients.FEV1/FVC, FEV1 % predicted and lung densitometry related to MMEF % pred (r2=0.778, p<0.0001; r2=0.787, p<0.0001; r2=0.594, p<0.0001, respectively) in a curvilinear fashion. Patients could be divided into those with normal FEV1/FVC and MMEF (group 1), normal FEV1/FVC and reduced MMEF (group 2) and those with spirometrically defined COPD (group 3). Patients in group 2 had worse health status than group 1 (median total St George's Respiratory Questionnaire (SGRQ) 23.15 (interquartile range (IQR) 7.09-39.63) versus 9.67 (IQR 1.83-22.35); p=0.006) and had a greater subsequent decline in FEV1 (median change in FEV1 -1.09% pred per year (IQR -1.91-0.04% pred per year) versus -0.04% pred per year (IQR -0.67-0.03% pred per year); p=0.007).A reduction in MMEF is an early feature of lung disease in AATD and is associated with impaired health status and a faster decline in FEV1.
引用
- Stockley JA, Ismail AM, Hughes SM, et al. Maximal mid-expiratory flow detects early lung disease in α1-antitrypsin deficiency. Eur Respir J. 2017. PMID: 28356373. doi:10.1183/13993003.02055-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。